Insulet (PODD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $138.77, +3.61% vs the prior close of $133.93.
- Volume 1.66M shares, 0.9x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
PODD jumps 3.6% to $138.77. Closed at $138.77, +3.61% vs the prior close of $133.93. Day range $136.02–$139.69, opened at $136.51.
PODD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — PODD jumps 3.6% to $138.77
- Closed at $138.77, +3.61% vs the prior close of $133.93. Day range $136.02–$139.69, opened at $136.51.
- Volume was 1.66M shares, 0.9x its 50-day average of 1.79M.
- Price is -1.2% vs its 50-day average ($140.39) and -25.6% vs its 200-day average ($186.49).
- 52-week range $126.40–$354.88; today's close sits at 5% of that range, 60.9% below the 52-week high.
Oct 14, 2026 — PODD slides 3.0% to $133.93
- Closed at $133.93, -3.04% vs the prior close of $138.13. Day range $133.58–$139.75, opened at $139.72.
- Volume was 2.32M shares, 1.3x its 50-day average of 1.78M.
- Price is -4.5% vs its 50-day average ($140.28) and -28.5% vs its 200-day average ($187.23).
- 52-week range $126.40–$354.88; today's close sits at 3% of that range, 62.3% below the 52-week high.
Oct 13, 2026 — PODD dips 1.2% to $138.13
- Closed at $138.13, -1.20% vs the prior close of $139.81. Day range $137.12–$141.86, opened at $140.79.
- Volume was 1.35M shares, 0.8x its 50-day average of 1.78M.
- Price is -2.0% vs its 50-day average ($140.94) and -26.5% vs its 200-day average ($188.00).
- 52-week range $126.40–$354.88; today's close sits at 5% of that range, 61.1% below the 52-week high.
Oct 12, 2026 — PODD jumps 3.3% to $139.81, 3 up days in a row
- Closed at $139.81, +3.35% vs the prior close of $135.28. Day range $134.81–$140.22, opened at $134.81.
- Volume was 1.33M shares, 0.7x its 50-day average of 1.78M.
- Price is -1.2% vs its 50-day average ($141.57) and -25.9% vs its 200-day average ($188.76).
- 52-week range $126.40–$354.88; today's close sits at 6% of that range, 60.6% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — PODD rises 0.6% to $135.28
- Closed at $135.28, +0.60% vs the prior close of $134.47. Day range $133.72–$137.17, opened at $134.19.
- Volume was 865.40K shares, 0.5x its 50-day average of 1.79M — lighter than usual.
- Price is -4.8% vs its 50-day average ($142.08) and -28.6% vs its 200-day average ($189.49).
- 52-week range $126.40–$354.88; today's close sits at 4% of that range, 61.9% below the 52-week high.
Oct 8, 2026 — PODD ends flat (+0.1%) to $134.47
- Closed at $134.47, +0.08% vs the prior close of $134.36. Day range $132.86–$134.60, opened at $133.96.
- Volume was 1.56M shares, 0.9x its 50-day average of 1.78M.
- Price is -5.8% vs its 50-day average ($142.69) and -29.3% vs its 200-day average ($190.27).
- 52-week range $126.40–$354.88; today's close sits at 4% of that range, 62.1% below the 52-week high.
Oct 7, 2026 — PODD ends flat (-0.3%) to $134.36
- Closed at $134.36, -0.27% vs the prior close of $134.73. Day range $133.33–$137.10, opened at $134.94.
- Volume was 1.03M shares, 0.6x its 50-day average of 1.78M — lighter than usual.
- Price is -6.3% vs its 50-day average ($143.41) and -29.7% vs its 200-day average ($191.04).
- 52-week range $126.40–$354.88; today's close sits at 3% of that range, 62.1% below the 52-week high.
Oct 6, 2026 — PODD dips 0.7% to $134.73
- Closed at $134.73, -0.66% vs the prior close of $135.62. Day range $133.73–$136.16, opened at $135.77.
- Volume was 1.71M shares, 1.0x its 50-day average of 1.77M.
- Price is -6.5% vs its 50-day average ($144.08) and -29.8% vs its 200-day average ($191.84).
- 52-week range $126.40–$354.88; today's close sits at 4% of that range, 62.0% below the 52-week high.
Oct 5, 2026 — PODD rises 3.0% to $135.62, 3 up days in a row
- Closed at $135.62, +2.98% vs the prior close of $131.69. Day range $131.23–$135.81, opened at $131.69.
- Volume was 1.94M shares, 1.1x its 50-day average of 1.76M.
- Price is -6.3% vs its 50-day average ($144.68) and -29.6% vs its 200-day average ($192.61).
- 52-week range $126.40–$354.88; today's close sits at 4% of that range, 61.8% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — PODD rises 0.7% to $131.69
- Closed at $131.69, +0.69% vs the prior close of $130.79. Day range $128.01–$132.53, opened at $131.83.
- Volume was 3.06M shares, 1.8x its 50-day average of 1.72M.
- Price is -9.3% vs its 50-day average ($145.24) and -31.9% vs its 200-day average ($193.38).
- 52-week range $126.40–$354.88; today's close sits at 2% of that range, 62.9% below the 52-week high.
PODD latest news & SEC filings
Every SEC filing by or about PODD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Pease Flavia had withheld for taxes 1,882 shares at $130.79 (≈$246.15K) on Oct 1, 2026; now holds 17,357
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mazelsky Jonathan Jay received an award of 141 shares at $130.47 (≈$18.40K) on Sep 30, 2026; now holds 1,496
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 2, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Huffines Robert Luther received an award of 178 shares at $130.47 (≈$23.22K) on Sep 30, 2026; now holds 2,627
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 21, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.03 — Took on a new material debt or financial obligation.
Sep 16, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 10, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 24, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mcevoy Ashley bought 1,100 shares at $147.47 (≈$162.22K) on Aug 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $801.70M (prior year $649.10M) (+23.5% vs Jun 30, 2025)
- Net income: $95.00M (prior year $22.50M) (+322.2% vs Jun 30, 2025)
- Diluted EPS: $1.37 (prior year $0.32) (+328.1% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 7, 2026 · 4/A — Amended insider trade report (Form 4/A)
Amended insider trade report (Form 4/A)
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade PODD
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Feb 18, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.27% (largest 3.6%).
- Liquidity: about 1.64M shares (≈$227.85M) trade per day on average.
- 52-week position: $138.77 vs a range of $126.40–$354.88 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 6 open-market buys, 2 sales; latest: Ashley Mcevoy bought 1,100 shares on Aug 21, 2026.
- Latest filings: 8-K Sep 21, 2026; 8-K Sep 16, 2026; 8-K Sep 10, 2026.
- Share count: 69.35M shares outstanding (Jul 29, 2026), -1.5% vs a year earlier.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
PODD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 136.51 | 139.69 | 136.02 | 138.77 | 1.66M |
| Oct 14, 2026 | 139.72 | 139.75 | 133.58 | 133.93 | 2.32M |
| Oct 13, 2026 | 140.79 | 141.86 | 137.12 | 138.13 | 1.35M |
| Oct 12, 2026 | 134.81 | 140.22 | 134.81 | 139.81 | 1.33M |
| Oct 9, 2026 | 134.19 | 137.17 | 133.72 | 135.28 | 865.40K |
| Oct 8, 2026 | 133.96 | 134.60 | 132.86 | 134.47 | 1.56M |
| Oct 7, 2026 | 134.94 | 137.10 | 133.33 | 134.36 | 1.03M |
| Oct 6, 2026 | 135.77 | 136.16 | 133.73 | 134.73 | 1.71M |
| Oct 5, 2026 | 131.69 | 135.81 | 131.23 | 135.62 | 1.94M |
| Oct 2, 2026 | 131.83 | 132.53 | 128.01 | 131.69 | 3.06M |
| Oct 1, 2026 | 131.78 | 132.02 | 128.75 | 130.79 | 3.26M |
| Sep 30, 2026 | 132.93 | 133.15 | 130.10 | 130.47 | 1.42M |
| Sep 29, 2026 | 132.58 | 133.49 | 130.80 | 132.84 | 1.37M |
| Sep 28, 2026 | 134.44 | 135.40 | 130.39 | 133.11 | 1.72M |
| Sep 25, 2026 | 135.78 | 138.06 | 134.48 | 136.13 | 1.06M |
| Sep 24, 2026 | 136.80 | 139.35 | 134.55 | 135.78 | 1.09M |
| Sep 23, 2026 | 139.07 | 139.82 | 134.73 | 136.49 | 1.02M |
| Sep 22, 2026 | 141.93 | 142.04 | 137.60 | 139.38 | 1.25M |
| Sep 21, 2026 | 140.60 | 141.49 | 138.59 | 140.53 | 1.34M |
| Sep 18, 2026 | 141.25 | 142.17 | 139.96 | 140.60 | 2.51M |
About Insulet
Insulet (PODD) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in ACTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1145197.
PODD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Luciana Borio | Director | Jun 4, 2026 |
| Wayne A.I. Frederick | Director | May 21, 2026 |
| Jessica Hopfield | Director | May 21, 2026 |
| Robert Luther Huffines | Director | Jul 7, 2026 |
| Jonathan Jay Mazelsky | Director | Jul 2, 2026 |
| Michael R Minogue | Director | May 21, 2026 |
| Ashley Mcevoy | President and CEO | Aug 24, 2026 |
| Timothy C. Stonesifer | Director | Jun 4, 2026 |
| Timothy J Scannell | Director | May 21, 2026 |
| Elizabeth H Weatherman | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Eric Benjamin | EVP and COO | Mar 3, 2026 |
| Lauren Budden | Group VP, CAO and Controller | Mar 3, 2026 |
| Laetitia Cousin | SVP, Reg, Quality & Compliance | Mar 3, 2026 |
| Lisa Blair Davis | SVP, Chief HR Officer | Aug 4, 2026 |
| John W. Kapples | SVP and General Counsel | Mar 3, 2026 |
| Ashley Mcevoy | President and CEO | Aug 24, 2026 |
| Michael Panos | EVP and CCO | Apr 2, 2026 |
| Flavia Pease | EVP & CFO | Feb 26, 2026 |
| Prem Singh | SVP, Global Operations | Mar 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 21, 2026 | Ashley Mcevoy | Buy | 1,100 | $147.47 |
| Jun 3, 2026 | Luciana Borio | Sale | 418 | $143.27 |
| Jun 3, 2026 | Timothy C. Stonesifer | Buy | 2,790 | $143.51 |
| Jun 3, 2026 | Elizabeth H Weatherman | Buy | 3,450 | $144.20 |
| Feb 25, 2026 | Michael R Minogue | Buy | 2,030 | $246.23 |
| Feb 20, 2026 | Ashley Mcevoy | Buy | 4,300 | $239.35 |
| Dec 15, 2025 | Wayne A.I. Frederick | Sale | 1,851 | $293.09 |
| Dec 5, 2025 | Timothy C. Stonesifer | Buy | 962 | $311.73 |
PODD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $247.10M | 3.48 | $569.30M |
| Dec 31, 2024 | — | $418.30M | 5.78 | $430.20M |
| Dec 31, 2023 | — | $206.30M | 2.94 | $145.70M |
| Dec 31, 2022 | $1.06B | $4.60M | 0.07 | $119.00M |
| Dec 31, 2021 | $1.04B | $16.80M | 0.24 | $-68.10M |
Latest balance sheet: total assets $3.17B, total liabilities $1.74B, cash $856.60M (as of Jun 30, 2026).
PODD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $133.26 |
| May 6, 2026 | 8-K Item 2.02 (results) | $151.28 |
| Feb 18, 2026 | 8-K Item 2.02 (results) | $258.07 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $323.40 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $303.55 |
| May 8, 2025 | 8-K Item 2.02 (results) | $257.00 |
| Feb 20, 2025 | 8-K Item 2.02 (results) | $288.29 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $244.98 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| Jul 26, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)West Pharmaceutical Services (WST)Globus Medical (GMED)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on PODD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.